Valuation : genOway

Market Cap 22.77M 26.43M 21.56M 19.55M 36.67M 2.53B 36.85M 256M 98.49M 1.28B 99.27M 97.09M 4.06B P/E 2024 *
-
P/E 2025 -
Enterprise Value 29.49M 34.23M 27.92M 25.31M 47.49M 3.27B 47.73M 332M 128M 1.66B 129M 126M 5.26B EV / Sales 2024
1.28x
EV / Sales 2025 1.11x
Free-Float
59.02%
Yield 2024 *
-
Yield 2025 -
1 day-1.20%
1 week-0.40%
Current month-0.40%
1 month-1.20%
3 months+2.92%
6 months+3.78%
Current year-8.86%
1 week 2.46
Extreme 2.46
2.5
1 month 2.4
Extreme 2.4
2.53
Current year 2.18
Extreme 2.18
2.79
1 year 2.1
Extreme 2.1
3.2
3 years 2.1
Extreme 2.1
4.91
5 years 2.1
Extreme 2.1
4.91
10 years 1
Extreme 1
7.7
Manager TitleAgeSince
Chief Executive Officer - -
Chief Operating Officer - 01/03/1999
Director of Finance/CFO - 01/10/2015
Director TitleAgeSince
Director/Board Member - 01/03/1999
Chairman - -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap. Importance
20/1/22 Buy

Chief Executive Officer

12,500 0.1376%
17/11/21 Sell

Chief Executive Officer

5,000 0.0553%
13/11/21 Sell

Founder

1,147 0.0127%
Change 5-day change 1-year change 3-year change Capi.($)
-1.20%-0.40%-12.10%-31.58% 26.8M
-0.71%-6.35%-4.87%+9.03% 46.05B
+0.21%-2.98%+340.68%+519.93% 43.59B
+1.74%-2.24%+37.28%+21.57% 42.35B
+1.38%-3.28%+3.23%+65.60% 38.86B
-1.44%-5.26%+8.78%+36.85% 32.24B
+0.87%-2.60% - - 17.16B
+0.75%-0.64%+18.07%+110.32% 16.28B
-0.31%-2.78%+10.47%+30.49% 14.32B
+1.93%-3.55%+74.20%+39.37% 13.03B
Average +0.32%-3.84%+52.86%+89.06% 26.39B
Weighted average by Cap. +0.40%-4.51%+73.04%+123.50%

Financials

2024 2025
Net sales 27.53M 31.95M 26.07M 23.63M 44.33M 3.05B 44.55M 310M 119M 1.55B 120M 117M 4.91B 28.6M 33.19M 27.08M 24.55M 46.05M 3.17B 46.28M 322M 124M 1.61B 125M 122M 5.1B
Net income 1.83M 2.12M 1.73M 1.57M 2.95M 203M 2.96M 20.59M 7.92M 103M 7.98M 7.8M 326M 928K 1.08M 878K 796K 1.49M 103M 1.5M 10.43M 4.01M 52.34M 4.04M 3.96M 165M
Net Debt 623K 723K 590K 535K 1M 69.08M 1.01M 7.01M 2.69M 35.14M 2.72M 2.66M 111M 6.72M 7.8M 6.36M 5.77M 10.82M 745M 10.87M 75.55M 29.05M 379M 29.28M 28.64M 1.2B
Logo genOway
genOway est une société de biotechnologie spécialisée dans la conception et le développement de modèles de recherche moléculaires, cellulaires et animaux à forte valeur ajoutée pour les industries biopharmaceutique, chimique, agrochimique et agroalimentaire ainsi que pour la recherche académique. genOway est une société leader sur son marché. Elle appuie son développement sur la combinaison d'une large et exclusive plateforme technologique et d'une propriété intellectuelle forte combinant brevets et licences d'exploitation. genOway a conclu de nombreux contrats commerciaux avec les leaders de l'industrie pharmaceutique (BMS, Janssen, Novartis, Pfizer, etc.), et avec les centres de recherche académiques les plus prestigieux (King's College et Université de Manchester en Angleterre, Harvard, Caltech et le National Institute of Health aux Etats-Unis, l'Institut Pasteur en France, le NGFN et l'Institut Max Planck en Allemagne, etc.).
Employees
157
Date Price Change Volume
11/09/26 EUR 2.470 -1.20% 1,007
10/09/26 EUR 2.500 0.00% 821
09/09/26 EUR 2.500 +1.21% 212
08/09/26 EUR 2.470 -0.40% 800
07/09/26 EUR 2.480 0.00% 3,010
  1. Stock Market
  2. Stocks
  3. ALGEN Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!